These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22083001)

  • 1. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and new treatments.
    Brugha RE; Davies JC
    Br J Hosp Med (Lond); 2011 Nov; 72(11):614-9. PubMed ID: 22083001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonal infection in cystic fibrosis: the battle continues.
    Elkin S; Geddes D
    Expert Rev Anti Infect Ther; 2003 Dec; 1(4):609-18. PubMed ID: 15482158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating resistant Pseudomonas aeruginosa lung disease in young children with cystic fibrosis.
    Lim SZP; Fitzgerald DA
    Paediatr Respir Rev; 2018 Jun; 27():33-36. PubMed ID: 29033215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaerobic biofilm infections in cystic fibrosis.
    Costerton JW
    Mol Cell; 2002 Oct; 10(4):699-700. PubMed ID: 12419212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis.
    Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J
    Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas infections in cystic fibrosis.
    George RH
    Arch Dis Child; 1987 May; 62(5):438-9. PubMed ID: 3111389
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of multiresistant Pseudomonas aeruginosa infection in cystic fibrosis: how to progress?].
    Burgel PR; Kanaan R
    Rev Mal Respir; 2010 May; 27(5):411-3. PubMed ID: 20569871
    [No Abstract]   [Full Text] [Related]  

  • 10. Diversification of Pseudomonas aeruginosa within the cystic fibrosis lung and its effects on antibiotic resistance.
    Clark ST; Guttman DS; Hwang DM
    FEMS Microbiol Lett; 2018 Mar; 365(6):. PubMed ID: 29401362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New antimicrobials in the management of cystic fibrosis.
    Høiby N
    J Antimicrob Chemother; 2002 Feb; 49(2):235-8. PubMed ID: 11815562
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies.
    Hassett DJ; Korfhagen TR; Irvin RT; Schurr MJ; Sauer K; Lau GW; Sutton MD; Yu H; Hoiby N
    Expert Opin Ther Targets; 2010 Feb; 14(2):117-30. PubMed ID: 20055712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-resistant Pseudomonas aeruginosa ST235 in cystic fibrosis.
    Lee AC; Jones AL
    Paediatr Respir Rev; 2018 Jun; 27():18-20. PubMed ID: 29914746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection.
    Costerton JW
    Trends Microbiol; 2001 Feb; 9(2):50-2. PubMed ID: 11173226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies.
    Pang Z; Raudonis R; Glick BR; Lin TJ; Cheng Z
    Biotechnol Adv; 2019; 37(1):177-192. PubMed ID: 30500353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pseudomonas aeruginosa genome: how do we use it to develop strategies for the treatment of patients with cystic fibrosis and Pseudomonas infections?
    Erwin AL; VanDevanter DR
    Curr Opin Pulm Med; 2002 Nov; 8(6):547-51. PubMed ID: 12394165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis.
    Ferreira AG; Leão RS; Carvalho-Assef AP; Folescu TW; Barth AL; Marques EA
    APMIS; 2010 Aug; 118(8):606-12. PubMed ID: 20666742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the CFTR in susceptibility to Pseudomonas aeruginosa infections in cystic fibrosis.
    Goldberg JB; Pier GB
    Trends Microbiol; 2000 Nov; 8(11):514-20. PubMed ID: 11121762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
    Evans TJ
    Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.